Author

Nina Langeland

University of Bergen - Cited by 9,789 - infectious diseases

Biography

Nina Langeland is immunology professor Institute of Medicine, University of Bergen, N-5021 Bergen, Norway Nina Langeland. His research interests includes Medicine. He is serving as an editorial member and reviewer of several international reputed journals. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Long COVID in a prospective cohort of home-isolated patients
B Blomberg, KGI Mohn, KA Brokstad, F Zhou, DW Linchausen, ...Nature medicine 27 (9), 1607-1613, 2021202
477
2021
Performance and operational feasibility of two diagnostic tests for cryptosporidiosis in children (CRYPTO-POC): a clinical, prospective, diagnostic accuracy study
ØH Johansen, A Abdissa, M Zangenberg, Z Mekonnen, B Eshetu, ...The Lancet Infectious Diseases 21 (5), 722-730, 2021202
15
2021
Long COVID: A growing problem in need of intervention
B Blomberg, RJ Cox, N LangelandCell Reports Medicine 3 (3), 2022202
14
2022
Human organotypic airway and lung organoid cells of bronchiolar and alveolar differentiation are permissive to infection by influenza and SARS-CoV-2 respiratory virus
CT Ekanger, F Zhou, D Bohan, ML Lotsberg, M Ramnefjell, L Hoareau, ...Frontiers in Cellular and Infection Microbiology, 208, 2022202
12
2022
Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients
KGI Mohn, G Bredholt, F Zhou, A Madsen, TB Onyango, EB Fjelltveit, ...PloS one 17 (2), e02617, 2022202
9
2022
Multiplexed measurement of binding-and neutralizing antibodies to SARS-CoV-2 variants in 12.000 post-vaccine sera
TT Tran, EB Vaage, A Mehta, A Chopra, A Kolderup, A Anthi, M König, ...BioRxiv, 2022.03. 26.484261, 2022202
7
2022
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
TT Tran, EB Vaage, A Mehta, A Chopra, L Tietze, A Kolderup, A Anthi, ...npj Vaccines 7 (1), 174, 2022202
6
2022
Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection-a case-control study
Symptom burden and immune dynamics to 18 months following mild SARS-CoV-2 infection-a case-control studyEB Fjelltveit, B Blomberg, K Kuwelker, F Zhou, TB Onyango, KA Brokstad, ...Oxford University Press, 2022202
6
2022
Symptom burden and immune dynamics 6 to 18 months following mild severe acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): a case-control study
EB Fjelltveit, B Blomberg, K Kuwelker, F Zhou, TB Onyango, KA Brokstad, ...Clinical Infectious Diseases 76 (3), e60-e70, 2023202
5
2023
Use of probiotics to reduce infections and death and prevent colonization with extended-spectrum beta-lactamase (ESBL)-producing bacteria among newborn infants in Tanzania …
K Kuwelker, N Langeland, IH Löhr, J Gidion, J Manyahi, SJ Moyo, ...Trials 22 (1), 312, 2021202
4
2021
IL-18 and IL-18 binding protein are related to disease severity and parasitemia during falciparum malaria
K Otterdal, A Berg, AE Michelsen, A Yndestad, S Patel, I Gregersen, ...BMC Infectious Diseases 21 (1), 1-10, 2021202
4
2021
Durable immune responses after BNT162b2 vaccination in home-dwelling old adults
L Hansen, KA Brokstad, A Bansal, F Zhou, G Bredholt, TB Onyango, ...Vaccine: X 13, 100262, 2023202
4
2023
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern
NU Ertesvåg, J Xiao, F Zhou, S Ljostveit, H Sandnes, S Lartey, M Sævik, ...Communications Medicine 2 (1), 6, 2022202
3
2022
Molecular characterisation of the first New Delhi metallo-β-lactamase 1-producing Acinetobacter baumannii from Tanzania
SJ Moyo, J Manyahi, ATM Hubbard, RL Byrne, NS Masoud, S Aboud, ...Transactions of The Royal Society of Tropical Medicine and Hygiene 115 (9 …, 2021202
3
2021
Spatiotemporal variation in risk of Shigella infection in childhood: a global risk mapping and prediction model using individual participant data
HS Badr, JM Colston, NLH Nguyen, YT Chen, E Burnett, SA Ali, ...The Lancet Global Health 11 (), e7-e84, 20220
3
2023
First identification of bla NDM-5 producing Escherichia coli from neonates and a HIV infected adult in Tanzania
J Manyahi, SJ Moyo, U Kibwana, RN Goodman, E Allman, ATM Hubbard, ...Journal of Medical Microbiology 71 (2), 2022202
3
2022
Malaria prevalence and performance of diagnostic tests among patients hospitalized with acute undifferentiated fever in Zanzibar
A Onken, CG Haanshuus, MK Miraji, M Marijani, KO Kibwana, KA Abeid, ...Malaria Journal 21 (1), 54, 2022202
3
2022
Point-of-Care Influenza Testing Impacts Clinical Decision, Patient Flow, and Length of Stay in Hospitalized Adults
EB Fjelltveit, RJ Cox, J Østensjø, B Blomberg, MH Ebbesen, N Langeland, ...The Journal of Infectious Diseases 226 (1), 97-108, 2022202
3
2022
Prevalence of fibromyalgia 10 years after infection with Giardia lamblia: a controlled prospective cohort study
GS Hunskar, G Rortveit, S Litleskare, GE Eide, K Hanevik, N Langeland, ...Scandinavian Journal of Pain 22 (2), 48-55, 2022202
3
2022
Oocyst Shedding Dynamics in Children with Cryptosporidiosis: a Prospective Clinical Case Series in Ethiopia
ØH Johansen, A Abdissa, O Bjørang, M Zangenberg, B Sharew, Y Alemu, ...Microbiology spectrum 10 (4), e0741-1, 0
2
2022

Referred From: https://scholar.google.com/citations?hl=en&user=lFbH5SMAAAAJ

Cited by
Citations 9789
h-index 55
i10-index 160
Recommended Journals
Open Access Journals